Updated On: 08 December, 2021 12:48 PM IST | Johannesburg | IANS
The emergence of the Omicron variant of SARS-CoV-2 in November in South Africa has raised concerns that based on the large number of mutations in the spike protein and elsewhere on the virus, this variant will have considerable escape from vaccine elicited immunity

Representational Image
Pfizer`s mRNA-based Covid vaccine may be up to 40 times less effective against the new super mutant Omicron variant, a small study led by South African researchers have shown.
The emergence of the Omicron variant of SARS-CoV-2 in November in South Africa has raised concerns that based on the large number of mutations in the spike protein and elsewhere on the virus, this variant will have considerable escape from vaccine elicited immunity.